January is Cervical Cancer Awareness Month, and this is great time to schedule a Pap test, which is a diagnostic procedure that can detect precancerous and cancerous cells in the...

As 2022 begins, Cervical Cancer Awareness Month arrives to remind us that there is a cancer that scientists and physicians have really gotten a handle on — as long as...

  Robert Kang, M.D., M.P.H. Few cancers are as frightening as tumors of the head and neck. The possibilities of loss of function, as well as disfigurement, make these cancers particularly...

There are several types of gynecologic cancers that affect the female reproductive system, including endometrial, ovarian, cervical, vaginal and vulvar cancer.   In the case of cervical cancer...

Erminia Massarelli, M.D., Ph.D., M.S. A first-in-human, phase 1 T cell trial for patients who have human papillomavirus (HPV)-associated cancers that have relapsed, or are resistant to treatment, is now open...

CONTACT Letisia Marquez 626-218-3398lemarquez@coh.org   On the West Coast, City of Hope is the first institution to open the Kite-sponsored trial   DUARTE, Calif. — The first-in-human, phase 1...

CONTACTO Letisia Marquez 626-476-7593lemarquez@coh.org   La pandemia de COVID-19 ha interrumpido la prestación de servicios médicos clave para niños y adolescentes, incluida la vacunación contra el VPH para prevenir...

Cancers of the head and neck frighten patients, but there are new methodologies that should ease minds, according to Thomas Gernon, M.D., surgeon in the Division of Head and Neck...

An estimated 20,000 to 30,000 human papillomavirus-associated cancers are diagnosed annually in the United States. HPV16-induced cancers, a strain that causes about 70% of all cervical cancers worldwide, are ideal candidates...

Since screening for cervical cancer was first initiated in the 1950s, the number of deaths from this disease has been drastically reduced. Nevertheless, nearly 14,000 women will be diagnosed with invasive...